With 200 experts, Genethon is pursuing its mission to bring life-changing gene therapy products to patients suffering from rare genetic diseases

Joined May 2015
470 Photos and videos
Proud to see our teams recognized internationally! Congrats to Djunda Peltier, finalist for the #CommunicationAward @UFMyology Her project: a new preclinical model AI tool to better understand and treat calpainopathy. 👉 Like & support her on X: x.com/ufmyology/status/20596…

Announcing the 4 finalist for the New Directions Conference Communication Award (in no particular order)! Vote for your favorite video and the trainee with the most likes wins! @MYOTWlTTER Finalist #2 of 4: Djunda Peltier
1
2
114
Fiers de voir nos équipes reconnues à l’international ! Bravo à notre collaboratrice Djunda Peltier, finaliste du #CommunicationAward @UFMyology 👉 Soutenez son projet en likant sur X : x.com/ufmyology/status/20596…

Announcing the 4 finalist for the New Directions Conference Communication Award (in no particular order)! Vote for your favorite video and the trainee with the most likes wins! @MYOTWlTTER Finalist #2 of 4: Djunda Peltier
1
3
137
📢[COMMUNIQUE DE PRESSE] @GenethonFr × @AmpersandBio Un partenariat exclusif pour concevoir des vecteurs AAV à très haute spécificité tissulaire, afin de renforcer la sécurité et l’efficacité des thérapies géniques. 👉urlr.me/AhbdXc #GeneTherapy #AAV #Innovation
2
103
📢[PRESS RELEASE] @GenethonFr × @AmpersandBio An exclusive partnership to engineer AAV vectors with very high tissue specificity, aiming to enhance the safety and efficacy of gene therapies. 👉 urlr.me/9B3dMJ #GeneTherapy #AAV #Innovation
101
[#ASGCT2026] – Oral presentations 📌Join us for @GenethonFr 's last talks at ASGCT 2026 with: Gérald Perret, Giuseppe Ronzitti and Paola Galbiati Advancing clinical gene therapy for rare diseases. @ASGCTherapy #GeneTherapy #ClinicalTrials
1
2
132
[#ASGCT2026] - Poster session 🤝👨‍🎓 👩‍🎓Meet Genethon scientists presenting: Estelle Creoff - Poster [ASGCT353] Adrian Westhaus - Poster [ASGCT1167] Isabelle Richard - Poster [ASGCT1489] Youssef Krimi Benchekroun - Poster [ASGCT1891] Rim Harb - Poster [ASGCT2476] @ASGCTherapy
2
1
3
134
[#ASGCT2026] – Oral presentation today, Isabelle Richard, PhD will share expert insights on: 🧬 Challenges and solutions in the development of gene therapy for muscular dystrophies A key session not to miss. @ASGCTherapy #GeneTherapy #MuscularDystrophy #DMD
1
3
101
🤝👨‍🎓 👩‍🎓[#ASGCT2026] - Poster session Meet our teams, discover @GenethonFr's work on genome editing, safety and preclinical models: Lydie Debaize - Poster [ASGCT1193] Jérôme Denard - Poster [ASGCT1220] Badih Salman - Poster [ASGCT870] @ASGCTherapy #geneediting #genetherapy
4
97
[#ASGCT2026] – Oral presentations today 📌Don’t miss oral presentations with Youssef Krimi Benchekroun, Louisa Jauze, Dr. Barry Byrne and Giulia Scalisi. @ASGCTherapy #GeneTherapy #RareDiseases
3
113
[#ASGCT2026] – Poster sessions 📌🤝Explore @GenethonFr's research in gene therapy and genome editing: Estelle Creoff - Poster [ASGCT355] Philippe Veron - Poster [ASGCT1186] Alexandra Tachtsidi - Poster [ASGCT1368] Rim Harb - Poster [ASGCT1830] Marion Derome - Poster [ASGCT1163]
74
📢 The 29th Annual #ASGCT2026 Congress kicks off today 11, in Boston, MA! @GenethonFr will present 21 scientific contributions: - 8 oral presentations - 13 posters! urlr.me/FYrAy4 Looking forward to sharing our latest advances in gene therapy! #GeneTherapy
1
150
🔬 Evaluating a single treatment across multiple diseases that share a common biological mechanism: a promising “basket” clinical trial approach to accelerate therapeutic innovation. 👉urls.fr/yjE3ki @Telethon_France @Inst_Myologie @IStemFrance #ClinicalTrials
1
79
🔬 Évaluer un même traitement dans plusieurs maladies partageant un mécanisme biologique commun: une approche prometteuse des essais cliniques "basket" pour accélérer l’innovation thérapeutique. 👉urlr.me/4eAqpC @Telethon_France @Inst_Myologie @IStemFrance # essais
2
2
127
#ASGCT2026 | Genethon at @ASGCTherapy Efficacy data from 3 gene therapy trials: pivotal GNT0004 (Duchenne), first clinical results of ATA200 (LGMD R5), and first‑in‑patient proof that imlifidase can overcome pre‑existing AAV immunity. 8 talks, 13 posters. urlr.me/t9qXkJ
3
5
334
⏰ Good morning fellow #CGMED26 attendees! Day 1 of the conference is underway. Don’t miss @GenethonFr's activities presentation by Imen Mestiri, PhD, Business Development Lead, April 29th at 3:45 pm. #GeneTherapy #RareDiseases #BusinessDevelopment #Genother
62
New study in Molecular Therapy: @GenethonFr uses #CRISPRCas9 to boost utrophin expression in #Duchenne muscular dystrophy. A mutation‑independent genome editing strategy with promising preclinical benefits. 👉urlr.me/GRYk8Q #GeneTherapy #GenomeEditing #DMD
1
5
180
Nouvelle étude dans Molecular Therapy : @GenethonFr utilise l’#éditiondugénome #CRISPRCas9 pour augmenter l’expression de l’utrophine dans la myopathie de #Duchenne. Une stratégie indépendante des mutations, prometteuse en préclinique. 👉urlr.me/U3faPe #DMD
1
1
4
162
GENETHON France retweeted
🎉 100 548 314 € collectés pour le Téléthon 2025 ! Grâce à vous : donateurs, bénévoles, familles, partenaires, chercheurs, grâce à @jesuissanta999, aux artistes, animateurs et aux équipes de @Francetele, cette collecte est EXCEPTIONNELLE ! MERCI 💛 👉 afm-telethon.fr/fr/actualite…
2
25
39
1,126
@GenethonFr at #SFTCG2026: 4 talks & 8 posters at @ICMParis advancing safe, effective gene therapies. AAV, CRISPR, new preclinical models, immune tolerance, rAAV manufacturing… Meet our teams! 📄 Full program: sftcg.fr/event-programme
1
101
@GenethonFr au #SFTCG2026 : 4 talks & 8 posters au @ICMParis pour faire avancer des thérapies géniques sûres et efficaces. AAV, CRISPR, nouveaux modèles précliniques, tolérance immunitaire, production de rAAV… Rencontrez nos équipes ! Programme: sftcg.fr/event-programme
1
75